Bibliographie (2530)
Count the cost of disability caused by COVID-19 – “Focusing only on cases and deaths hides the pandemic’s lasting health burden on people, societies and economies”.
jeudi, 27 mai 2021 11:02 Écrit par Zouhair SouissiCount the cost of disability caused by COVID-19 – Nature
The post Count the cost of disability caused by COVID-19 – “Focusing only on cases and deaths hides the pandemic’s lasting health burden on people, societies and economies”. appeared first on Links Medicus.
RCT: 2 inactivated SARS-CoV-2 vaccines show efficacy of 72.8% and 78.1% on symptomatic COVID-19 infection in adults.
jeudi, 27 mai 2021 11:02 Écrit par Zouhair SouissiEffect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial – JAMA Commentary: China’s Sinopharm Publishes Awaited Covid Vaccine Study Details – Bloomberg Commentary on Twitter (thread – click for more) The #4Humanity phase 3 trial of Sinopharm's Beijing & Wuhan vaccines published in JAMA by @NawalAlKaabi &co […]
The post RCT: 2 inactivated SARS-CoV-2 vaccines show efficacy of 72.8% and 78.1% on symptomatic COVID-19 infection in adults. appeared first on Links Medicus.
![[Preprint] Meta-analysis of RCT: Ivermectin for the treatment of COVID-19 – no effect on all-cause mortality, length of stay, or viral clearance](/media/k2/items/cache/e7d681ddc0174087ad0e36dc718519dd_M.jpg)
[Preprint] Meta-analysis of RCT: Ivermectin for the treatment of COVID-19 – no effect on all-cause mortality, length of stay, or viral clearance
mercredi, 26 mai 2021 13:30 Écrit par Zouhair SouissiIvermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials – medRxiv Commentary on Twitter ???PreprintIvermectin for the treatment of #COVID19 : A systematic review & meta-analysis of RCTs10 RCTs1173 patients 8 RCTs➡️ Mild1 RCT ➡️ Moderate1 RCT➡️ Mild& modIvermectin did not reduce all-cause mortality,length of stay or viral […]
The post [Preprint] Meta-analysis of RCT: Ivermectin for the treatment of COVID-19 – no effect on all-cause mortality, length of stay, or viral clearance appeared first on Links Medicus.
Estimating infectiousness throughout SARS-CoV-2 infection course – 8% of subjects had very high viral loads, one-third of whom had little to no symptoms; in individuals infected with the B.1.1.7 variant, average viral loads were 10 times higher.
mercredi, 26 mai 2021 13:30 Écrit par Zouhair SouissiEstimating infectiousness throughout SARS-CoV-2 infection course – Science Commentary: Estimating infectiousness of SARS-CoV-2: New study on viral load – Universitätsmedizin Berlin Commentary on Twitter Of 25,000+ people who tested positive for #COVID19 in Germany, 8% had very high viral loads; about a third of these had little to no symptoms. The results suggest asymptomatic […]
The post Estimating infectiousness throughout SARS-CoV-2 infection course – 8% of subjects had very high viral loads, one-third of whom had little to no symptoms; in individuals infected with the B.1.1.7 variant, average viral loads were 10 times higher. appeared first on Links Medicus.
COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence – “viral load was tenfold higher in P.1 infections than in non-P.1”.
mercredi, 26 mai 2021 13:30 Écrit par Zouhair SouissiCOVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence – Nature Medicine
The post COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence – “viral load was tenfold higher in P.1 infections than in non-P.1”. appeared first on Links Medicus.
What scientists know about new, fast-spreading coronavirus variants.
mercredi, 26 mai 2021 13:30 Écrit par Zouhair SouissiWhat scientists know about new, fast-spreading coronavirus variants – Nature
The post What scientists know about new, fast-spreading coronavirus variants. appeared first on Links Medicus.
Short review: Diagnosis and management of acute respiratory distress syndrome
mercredi, 26 mai 2021 10:21 Écrit par Zouhair SouissiDiagnosis and management of acute respiratory distress syndrome – Canadian Medical Association Journal Commentary on Twitter #ARDS is an important priority in our ICUs at the moment. Our @CMAJ review looks at diagnosis, and provides a guideline-based approach to management, along with a discussion on #COVID19 ARDS. A great primer for those new to […]
The post Short review: Diagnosis and management of acute respiratory distress syndrome appeared first on Links Medicus.
Perspective | Coronavirus: so many variants, but vaccines are still effective.
mardi, 25 mai 2021 11:08 Écrit par Zouhair SouissiCoronavirus: so many variants, but vaccines are still effective – The Conversation
The post Perspective | Coronavirus: so many variants, but vaccines are still effective. appeared first on Links Medicus.
Living systematic review: The evidence is insufficient to determine the benefits and harms of vitamin D supplementation as a treatment of COVID‐19.
mardi, 25 mai 2021 11:08 Écrit par Zouhair SouissiVitamin D supplementation for the treatment of COVID‐19: a living systematic review – Cochrane Library Summary: Is vitamin D an effective and safe treatment for COVID-19? – Cochrane Library
The post Living systematic review: The evidence is insufficient to determine the benefits and harms of vitamin D supplementation as a treatment of COVID‐19. appeared first on Links Medicus.
Secondary analysis of RCT finds Tocilizumab was beneficial to patients hospitalized with Covid-19 if CRP levels were greater than 15.0 mg/dL, but not if CRP levels were 15.0 mg/dL or less.
mardi, 25 mai 2021 11:08 Écrit par Zouhair SouissiEffectiveness of Tocilizumab in Patients Hospitalized With COVID-19: A Follow-up of the CORIMUNO-TOCI-1 Randomized Clinical Trial – JAMA Internal Medicine
The post Secondary analysis of RCT finds Tocilizumab was beneficial to patients hospitalized with Covid-19 if CRP levels were greater than 15.0 mg/dL, but not if CRP levels were 15.0 mg/dL or less. appeared first on Links Medicus.
